Brief: Transgene Reports Promising Efficacy Results With TG4001 In Combination With Avelumab

Transgene SA

30/09/2019 17:16

Sept 30 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE REPORTS FIRST PROMISING EFFICACY RESULTS WITH TG4001 IN COMBINATION WITH
AVELUMAB IN
HPV-POSITIVE CANCER AT ESMO 2019
    * THREE OF SIX PATIENTS SHOWED DURABLE RESPONSES (PATIENTS TREATED WITH RECOMMENDED PHASE 2
DOSE)
    * COMBINATION THERAPY RESULTS IN CHANGES IN TUMOR MICROENVIRONMENT SHIFTING IMMUNE STATUS
FROM
"COLD" TO "HOT"
    * CLINICAL TRIAL CONDUCTED IN COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY, AND PFIZER

Source text for Eikon:  ID:nBw4s12p1a 
Further company coverage:  TRNG.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))